Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 55/100

Failure Rate

16.7%

1 terminated/withdrawn out of 6 trials

Success Rate

75.0%

-11.5% vs industry average

Late-Stage Pipeline

50%

3 trials in Phase 3/4

Results Transparency

0 of 3 completed trials have results

Key Signals

Enrollment Performance

Analytics

N/A

3(50.0%)

Phase 4

3(50.0%)

6Total

N/A(3)

Phase 4(3)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (6)

Showing 6 of 6 trials

NCT05608239Not ApplicableUnknown

Safety and Efficacy of Injectable Poly-L-Lactic Acid for Volume Loss in the Temples Using Dual Plane Injections

Role: lead

NCT04957446Not ApplicableUnknown

Histology Study of Biostimulatory Activity of Injectable Poly-L-Lactic Acid (Sculptra Aesthetic)

Role: lead

NCT03052413Not ApplicableCompleted

Study to Evaluate a Nutraceutical Supplement for Treatment of Hair Loss and Thinning in Females

Role: lead

NCT02647528Phase 4Withdrawn

A Trial of Pulse Dyed Laser (Chromogenex Regenlite Transform) in the Treatment of Inflammatory Acne Vulgaris

Role: lead

NCT02003833Phase 4Completed

Poly-L-lactic Acid for Skin Quality

Role: lead

NCT02138539Phase 4Completed

Evaluation of an Herbal-Based De-Pigmenting System

Role: lead

All 6 trials loaded